13F HOLDINGS REPORT
Samsara BioCapital, LLC
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001104659-24-089652
Total Value
$477.8M
Positions
40
Other Managers
0
Confidential Omitted
No
Holdings (40)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CARGO THERAPEUTICS INC | 14179K101 | 4,415,689 | $72.5M | 15.17% |
| 2 | MINERALYS THERAPEUTICS INC | MLYS | 5,074,916 | $59.4M | 12.43% |
| 3 | SCHOLAR ROCK HLDG CORP | SRRK | 6,788,609 | $56.5M | 11.84% |
| 4 | NEUROGENE INC | NGNE | 1,267,790 | $46.1M | 9.66% |
| 5 | ARCELLX INC | ACLX | 453,641 | $25.0M | 5.24% |
| 6 | ELIEM THERAPEUTICS INC | CLYM | 3,261,393 | $23.2M | 4.85% |
| 7 | NKARTA INC | NKTX | 3,768,035 | $22.3M | 4.66% |
| 8 | LENZ THERAPEUTICS INC | LENZ | 1,208,473 | $20.9M | 4.37% |
| 9 | AVADEL PHARMACEUTICALS PLC | G29687103 | 967,527 | $13.6M | 2.85% |
| 10 | JASPER THERAPEUTICS INC | JSPRW | 525,000 | $11.9M | 2.49% |
| 11 | HILLEVAX INC | 43157M102 | 799,274 | $11.6M | 2.42% |
| 12 | ABIVAX SA | AAVXF | 850,000 | $11.2M | 2.35% |
| 13 | ACELYRIN INC | 00445A100 | 2,523,022 | $11.1M | 2.33% |
| 14 | CONTINEUM THERAPEUTICS INC | CTNM | 588,817 | $10.4M | 2.17% |
| 15 | SYROS PHARMACEUTICALS INC | 87184Q206 | 1,786,427 | $9.2M | 1.93% |
| 16 | ZYMEWORKS INC | ZYME | 1,000,000 | $8.5M | 1.78% |
| 17 | RHYTHM PHARMACEUTICALS INC | RYTM | 172,647 | $7.1M | 1.48% |
| 18 | INOZYME PHARMA INC | 45790W108 | 1,562,500 | $7.0M | 1.46% |
| 19 | SUTRO BIOPHARMA INC | STRO | 2,196,814 | $6.4M | 1.35% |
| 20 | GOSSAMER BIO INC | GOSS | 6,130,268 | $5.5M | 1.16% |
| 21 | TANGO THERAPEUTICS INC | TNGX | 630,000 | $5.4M | 1.13% |
| 22 | VERONA PHARMA PLC | 925050106 | 347,500 | $5.0M | 1.05% |
| 23 | LEAP THERAPEUTICS INC | CYPH | 2,442,352 | $4.8M | 1.00% |
| 24 | IO BIOTECH INC | IOBT | 3,640,015 | $4.3M | 0.89% |
| 25 | VTV THERAPEUTICS INC | VTVT | 206,784 | $3.7M | 0.76% |
| 26 | PRIME MEDICINE INC | PRME | 540,304 | $2.8M | 0.58% |
| 27 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 196,425 | $2.7M | 0.57% |
| 28 | IMMATICS N.V | IMTX | 198,000 | $2.3M | 0.48% |
| 29 | JANUX THERAPEUTICS INC | JANX | 45,052 | $1.9M | 0.39% |
| 30 | TERNS PHARMACEUTICALS INC | TERN | 202,348 | $1.4M | 0.29% |
| 31 | IGM BIOSCIENCES INC | 449585108 | 154,664 | $1.1M | 0.22% |
| 32 | BOLT BIOTHERAPEUTICS INC | BOLT | 1,049,153 | $786,865 | 0.16% |
| 33 | LYRA THERAPEUTICS INC | LYRA | 2,780,261 | $769,298 | 0.16% |
| 34 | ACLARIS THERAPEUTICS INC | ACRS | 696,171 | $765,788 | 0.16% |
| 35 | VIRACTA THERAPEUTICS INC | 92765F108 | 689,709 | $374,995 | 0.08% |
| 36 | ALLAKOS INC | 01671P100 | 172,089 | $172,089 | 0.04% |
| 37 | KRONOS BIO INC | 50107A104 | 78,131 | $96,882 | 0.02% |
| 38 | ALLOVIR INC | 019818103 | 82,336 | $59,554 | 0.01% |
| 39 | NUVATION BIO INC | NUVB | 133,333 | $21,333 | 0.00% |
| 40 | SURROZEN INC | SRZNW | 99,999 | $1,660 | 0.00% |